personalized medicine, genetics & genomics

Some of the blood specimens collected in the United States for the NIH’s All of Us research program starting on January 2, 2020, have antibodies against SARS-CoV-2.

The agency says it has taken various steps to ensure the privacy of participants’ data. 

The nationwide experiment will initially include around 100,000 volunteers.

Michael Christman oversaw the organization’s well-known biobank and pioneered a personalized medicine initiative.

As researchers sequence the DNA of thousands of kids with autism, dozens of genetic subgroups are emerging.

Researchers aim to leverage new insights into the underlying causes of the disorder to better help patients. 

Scientists can now buy the direct-to-consumer sequencing product, and research participants can join 23andMe’s database.

The genomic entrepreneur has struck a deal with a South African health insurer to sequence the exomes of its customers.

Personalized pancreatic cancer therapies based on tumor genomics may take too long to prepare to be helpful, according to a small clinical trial.

Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.

Cancer treatment becomes more and more personal.

Fully sequenced genomes of more than 100 Ashkenazi people clarify the group’s history and provide a reference for researchers and physicians trying to pinpoint disease-associated genes.

So-called laboratory-developed tests will eventually face regulations similar to those that currently govern diagnostic tests or kits that are sold to hospitals.

An algorithm can pick out biologically and clinically meaningful variants from whole-exome sequences of tumors.

The IBM supercomputer, famous for its game show performance, will aid in cloud-based analyses of genomic data.  

On creating communal, equitable discourse to broaden participation in genetics research

Researchers identify oral microbiome signatures that correlate with a person’s cultural background.

Highlights from a series of three webinars on the future of genome research, held by The Scientist to celebrate 60 years of the DNA double helix